XELOXCetuximabIrinotecanBevacizumabpalonosetronnetupitantafliberceptcolorectal cancerOncohaematology Pharmaceutical Care Clinicmoderately emetogenic chemotherapy
…uctured pharmacist-led follow-up. The excellent tolerability of XELOX, with no need for rescue therapy, suggests this subgroup could …